Literature DB >> 12060783

An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors.

Susan M Huang1, Tiziana Bisogno, Marcello Trevisani, Abdulmonem Al-Hayani, Luciano De Petrocellis, Filomena Fezza, Michele Tognetto, Timothy J Petros, Jocelyn F Krey, Constance J Chu, Jeffrey D Miller, Stephen N Davies, Pierangelo Geppetti, J Michael Walker, Vincenzo Di Marzo.   

Abstract

The vanilloid receptor VR1 is a nonselective cation channel that is most abundant in peripheral sensory fibers but also is found in several brain nuclei. VR1 is gated by protons, heat, and the pungent ingredient of "hot" chili peppers, capsaicin. To date, no endogenous compound with potency at this receptor comparable to that of capsaicin has been identified. Here we examined the hypothesis, based on previous structure-activity relationship studies and the availability of biosynthetic precursors, that N-arachidonoyl-dopamine (NADA) is an endogenous "capsaicin-like" substance in mammalian nervous tissues. We found that NADA occurs in nervous tissues, with the highest concentrations being found in the striatum, hippocampus, and cerebellum and the lowest concentrations in the dorsal root ganglion. We also gained evidence for the existence of two possible routes for NADA biosynthesis and mechanisms for its inactivation in rat brain. NADA activates both human and rat VR1 overexpressed in human embryonic kidney (HEK)293 cells, with potency (EC(50) approximately 50 nM) and efficacy similar to those of capsaicin. Furthermore, NADA potently activates native vanilloid receptors in neurons from rat dorsal root ganglion and hippocampus, thereby inducing the release of substance P and calcitonin gene-related peptide (CGRP) from dorsal spinal cord slices and enhancing hippocampal paired-pulse depression, respectively. Intradermal NADA also induces VR1-mediated thermal hyperalgesia (EC(50) = 1.5 +/- 0.3 microg). Our data demonstrate the existence of a brain substance similar to capsaicin not only with respect to its chemical structure but also to its potency at VR1 receptors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12060783      PMCID: PMC123079          DOI: 10.1073/pnas.122196999

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

Review 1.  New perspectives on enigmatic vanilloid receptors.

Authors:  A Szallasi; V Di Marzo
Journal:  Trends Neurosci       Date:  2000-10       Impact factor: 13.837

2.  Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia.

Authors:  J B Davis; J Gray; M J Gunthorpe; J P Hatcher; P T Davey; P Overend; M H Harries; J Latcham; C Clapham; K Atkinson; S A Hughes; K Rance; E Grau; A J Harper; P L Pugh; D C Rogers; S Bingham; A Randall; S A Sheardown
Journal:  Nature       Date:  2000-05-11       Impact factor: 49.962

3.  Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances.

Authors:  S W Hwang; H Cho; J Kwak; S Y Lee; C J Kang; J Jung; S Cho; K H Min; Y G Suh; D Kim; U Oh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 4.  The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes.

Authors:  C J Hillard; A Jarrahian
Journal:  Chem Phys Lipids       Date:  2000-11       Impact factor: 3.329

5.  Cloning and functional expression of a human orthologue of rat vanilloid receptor-1.

Authors:  Philip Hayes; Helen J Meadows; Martin J Gunthorpe; Mark H Harries; Malcolm D Duckworth; William Cairns; David C Harrison; Catherine E Clarke; Kathryn Ellington; Rab K Prinjha; Amanda J L Barton; Andrew D Medhurst; Graham D Smith; Simon Topp; Paul Murdock; Gareth J Sanger; John Terrett; Owen Jenkins; Christopher D Benham; Andrew D Randall; Isro S Gloger; John B Davis
Journal:  Pain       Date:  2000-11       Impact factor: 6.961

6.  Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.

Authors:  P M Zygmunt; J Petersson; D A Andersson; H Chuang; M Sørgård; V Di Marzo; D Julius; E D Högestätt
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

7.  N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.

Authors:  T Bisogno; D Melck; N M Gretskaya; V V Bezuglov; L De Petrocellis; V Di Marzo
Journal:  Biochem J       Date:  2000-11-01       Impact factor: 3.857

8.  The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1).

Authors:  D Smart; M J Gunthorpe; J C Jerman; S Nasir; J Gray; A I Muir; J K Chambers; A D Randall; J B Davis
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

9.  Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity.

Authors:  L De Petrocellis; T Bisogno; J B Davis; R G Pertwee; V Di Marzo
Journal:  FEBS Lett       Date:  2000-10-13       Impact factor: 4.124

10.  Impaired nociception and pain sensation in mice lacking the capsaicin receptor.

Authors:  M J Caterina; A Leffler; A B Malmberg; W J Martin; J Trafton; K R Petersen-Zeitz; M Koltzenburg; A I Basbaum; D Julius
Journal:  Science       Date:  2000-04-14       Impact factor: 47.728

View more
  251 in total

1.  Opposing roles for cannabinoid receptor type-1 (CB₁) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats.

Authors:  Plínio C Casarotto; Ana Luisa B Terzian; Daniele C Aguiar; Hélio Zangrossi; Francisco S Guimarães; Carsten T Wotjak; Fabrício A Moreira
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

Review 2.  The endocannabinoid system: a general view and latest additions.

Authors:  Luciano De Petrocellis; Maria Grazia Cascio; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

Review 3.  Cough. 5: The type 1 vanilloid receptor: a sensory receptor for cough.

Authors:  A H Morice; P Geppetti
Journal:  Thorax       Date:  2004-03       Impact factor: 9.139

Review 4.  The functions of TRPA1 and TRPV1: moving away from sensory nerves.

Authors:  E S Fernandes; M A Fernandes; J E Keeble
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 5.  International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family.

Authors:  Long-Jun Wu; Tara-Beth Sweet; David E Clapham
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

6.  N-acyl dopamines induce apoptosis in PC12 cell line via the GPR55 receptor activation.

Authors:  M G Akimov; A M Ashba; N M Gretskaya; V V Bezuglov
Journal:  Dokl Biochem Biophys       Date:  2017-07-20       Impact factor: 0.788

7.  Mitochondria and plasma membrane Ca2+-ATPase control presynaptic Ca2+ clearance in capsaicin-sensitive rat sensory neurons.

Authors:  Leonid P Shutov; Man-Su Kim; Patrick R Houlihan; Yuliya V Medvedeva; Yuriy M Usachev
Journal:  J Physiol       Date:  2013-02-04       Impact factor: 5.182

Review 8.  Anandamide and vanilloid TRPV1 receptors.

Authors:  Ruth A Ross
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

Review 9.  Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia.

Authors:  Armen N Akopian; Nikita B Ruparel; Nathaniel A Jeske; Amol Patwardhan; Kenneth M Hargreaves
Journal:  Trends Pharmacol Sci       Date:  2008-12-11       Impact factor: 14.819

10.  Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels.

Authors:  Mario van der Stelt; Marcello Trevisani; Vittorio Vellani; Luciano De Petrocellis; Aniello Schiano Moriello; Barbara Campi; Peter McNaughton; Piero Geppetti; Vincenzo Di Marzo
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.